HI
TXG icon

Handelsinvest Investeringsforvaltning’s 10x Genomics TXG Stock Holding History

Handelsinvest Investeringsforvaltning’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$150K Sell
3,993
-2,073
-34% -$91.1K 0.07% 304
2023
Q4 		$339K Buy
+6,066
New +$264K 0.14% 235

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Handelsinvest Investeringsforvaltning's TXG Position: Q1 2024 in Review

Handelsinvest Investeringsforvaltning reduced its 10x Genomics (TXG) stake by 34% in Q1 2024, selling an estimated $91.1K and leaving 3,993 shares worth $150K. The position accounts for 0.07% of the portfolio, ranked #304.

Handelsinvest Investeringsforvaltning first reported a position in TXG in Q4 2023 and has held it in 2 quarters since. The position peaked at $339K in Q4 2023. 290 funds tracked by Wall St. Rank hold TXG as of Q1 2024.

  • Handelsinvest Investeringsforvaltning held 3,993 shares of 10x Genomics worth $150K as of Q1 2024.
  • Handelsinvest Investeringsforvaltning sold 2,073 10x Genomics shares in Q1 2024, an estimated $91.1K.
  • 10x Genomics made up 0.07% of Handelsinvest Investeringsforvaltning's portfolio in Q1 2024, its #304 holding.
  • Handelsinvest Investeringsforvaltning first reported a position in 10x Genomics in Q4 2023 and has held it in 2 quarters since.
  • Handelsinvest Investeringsforvaltning's 10x Genomics position peaked at $339K in Q4 2023.
  • 290 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2024.

Based on Handelsinvest Investeringsforvaltning's 13F filing for Q1 2024, filed 19 Apr 2024.